Bausch Health Companies (BHC) News Today $7.03 -0.24 (-3.30%) Closing price 03:58 PM EasternExtended Trading$7.00 -0.04 (-0.50%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Bausch Health Companies Inc.: Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured NotesMarch 25 at 4:18 PM | finanznachrichten.deBausch Health Companies Inc.: Bausch Health Announces Conditional Redemption of Senior NotesMarch 23 at 10:27 PM | finanznachrichten.deNorthwest & Ethical Investments L.P. Raises Stock Holdings in Bausch Health Companies Inc. (NYSE:BHC)Northwest & Ethical Investments L.P. lifted its holdings in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 119.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,139 shares of theMarch 23 at 5:14 AM | marketbeat.comShareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years agoMarch 22 at 7:59 PM | finance.yahoo.comBausch Health Companies Inc.: Bausch Health Announces Launch of Syndication of New Senior Secured Credit FacilitiesMarch 19, 2025 | finanznachrichten.deBausch Health Companies Inc. (NYSE:BHC) Short Interest Down 17.0% in FebruaryBausch Health Companies Inc. (NYSE:BHC - Get Free Report) saw a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 6,450,000 shares, a drop of 17.0% from the February 13th total of 7,770,000 shares. Approximately 2.2% of the company's shares are sold short. Based on an average daily volume of 2,440,000 shares, the short-interest ratio is presently 2.6 days.March 19, 2025 | marketbeat.comBausch Health Launches $3.8 Billion Credit Facilities SyndicationMarch 19, 2025 | tipranks.comIntact Investment Management Inc. Acquires 72,300 Shares of Bausch Health Companies Inc. (NYSE:BHC)Intact Investment Management Inc. grew its holdings in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 38.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 261,300 shares of the company's stock after buying an adMarch 16, 2025 | marketbeat.comZacks Research Has Negative Forecast for BHC Q1 EarningsMarch 16, 2025 | americanbankingnews.comZacks Research Issues Negative Outlook for BHC EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Analysts at Zacks Research reduced their Q1 2025 EPS estimates for Bausch Health Companies in a research report issued to clients and investors on Tuesday, March 11th. Zacks Research analyst R. Department now anticipates that the company wilMarch 15, 2025 | marketbeat.comBausch Health announces next steps in financining initiativeMarch 14, 2025 | markets.businessinsider.comZacks Research Has Bullish Estimate for BHC Q2 EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Investment analysts at Zacks Research boosted their Q2 2025 EPS estimates for Bausch Health Companies in a report issued on Tuesday, March 11th. Zacks Research analyst R. Department now expects that the company will earn $1.05 per share forMarch 14, 2025 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Given Consensus Rating of "Reduce" by BrokeragesShares of Bausch Health Companies Inc. (NYSE:BHC - Get Free Report) have been given an average recommendation of "Reduce" by the seven research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and six have given a hold rMarch 7, 2025 | marketbeat.comBausch Health Companies Inc. (BHC): Among Top Stock Picks From Carl Icahn’s PortfolioMarch 1, 2025 | msn.comIs Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?February 27, 2025 | insidermonkey.comBausch Health Companies (NYSE:BHC) Shares Up 6.5% - What's Next?Bausch Health Companies (NYSE:BHC) Trading 6.5% Higher - Here's WhyFebruary 25, 2025 | marketbeat.comBausch Health Companies Inc. (BHC) J.P. Morgan Global Leveraged Finance Conference TranscriptFebruary 24, 2025 | seekingalpha.comVan ECK Associates Corp Sells 119,848 Shares of Bausch Health Companies Inc. (NYSE:BHC)Van ECK Associates Corp lessened its holdings in shares of Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 34.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 223,420 shares of the company's stock aFebruary 22, 2025 | marketbeat.comBausch + Lomb: Solid 2024 Results, But Let's Address The Elephant In The RoomFebruary 21, 2025 | seekingalpha.comBausch Health Companies (NYSE:BHC) Shares Gap Up - Still a Buy?Bausch Health Companies (NYSE:BHC) Shares Gap Up - Here's WhyFebruary 21, 2025 | marketbeat.comBausch Health Companies (NYSE:BHC) Releases Quarterly Earnings Results, Misses Expectations By $0.44 EPSBausch Health Companies (NYSE:BHC - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.65 by ($0.44). Bausch Health Companies had a negative net margin of 1.88% and a negative return on equity of 755.86%.February 20, 2025 | marketbeat.comBausch Health Companies (NYSE:BHC) Announces Quarterly Earnings ResultsBausch Health Companies (NYSE:BHC - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.65 by ($0.44). Bausch Health Companies had a negative return on equity of 755.86% and a negative net margin of 1.88%.February 20, 2025 | marketbeat.comBausch Health Q4 Earnings Recap (Reiterating Buy Rating)February 20, 2025 | seekingalpha.comBausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence RisesFebruary 20, 2025 | msn.comBausch Health Companies (BHC) Expected to Announce Quarterly Earnings on ThursdayBausch Health Companies (NYSE:BHC) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658685)February 20, 2025 | marketbeat.comBausch Health Companies Inc. (BHC) Q4 2024 Earnings Call TranscriptFebruary 19, 2025 | seekingalpha.comBausch Health Companies Inc.: Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance ConferenceFebruary 14, 2025 | finanznachrichten.deSkincare Devices Market and Competition Analysis 2025-2030, Featuring 42 Major Companies Including Alma Lasers, Bausch Health Companies, Lumenis, Merz Pharma & MoreFebruary 12, 2025 | globenewswire.comBausch Health Companies (BHC) to Release Quarterly Earnings on WednesdayBausch Health Companies (NYSE:BHC) will be releasing earnings after the market closes on Wednesday, February 19. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=658685)February 12, 2025 | marketbeat.comBest Stock to Buy Right Now: WELL Health vs Bausch Health?February 11, 2025 | ca.finance.yahoo.comBausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Reduce" by AnalystsBausch Health Companies Inc. (NYSE:BHC - Get Free Report) has been assigned an average recommendation of "Reduce" from the seven research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and six have issued a hold rating on theFebruary 10, 2025 | marketbeat.comJefferies Financial Group Reaffirms "Hold" Rating for Bausch Health Companies (NYSE:BHC)Jefferies Financial Group restated a "hold" rating and set a $8.00 price objective (down from $12.00) on shares of Bausch Health Companies in a research report on Thursday.February 6, 2025 | marketbeat.comContact lens maker Bausch + Lomb rules out take-private dealFebruary 6, 2025 | reuters.comPrivate Management Group Inc. Cuts Position in Bausch Health Companies Inc. (NYSE:BHC)Private Management Group Inc. decreased its position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 15.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,265,250 shares ofFebruary 6, 2025 | marketbeat.comBausch Health Companies (NYSE:BHC) Shares Down 5.2% - What's Next?Bausch Health Companies (NYSE:BHC) Stock Price Down 5.2% - Here's WhyFebruary 3, 2025 | marketbeat.comBHC:CA Bausch Health Companies Inc.February 2, 2025 | seekingalpha.comRoyal Bank of Canada Has Lowered Expectations for Bausch Health Companies (NYSE:BHC) Stock PriceRoyal Bank of Canada lowered their price target on Bausch Health Companies from $11.00 to $10.00 and set a "sector perform" rating for the company in a research report on Thursday.January 30, 2025 | marketbeat.comEquities Analysts Offer Predictions for BHC FY2025 EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Stock analysts at Zacks Research dropped their FY2025 earnings per share estimates for Bausch Health Companies in a research note issued on Monday, January 20th. Zacks Research analyst R. Department now anticipates that the company will postJanuary 23, 2025 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Shares Bought by SG Americas Securities LLCSG Americas Securities LLC raised its stake in Bausch Health Companies Inc. (NYSE:BHC - Free Report) by 62.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,301,981 shares of the company's stoJanuary 23, 2025 | marketbeat.comZacks Research Issues Positive Outlook for BHC EarningsBausch Health Companies Inc. (NYSE:BHC - Free Report) - Zacks Research upped their Q1 2025 earnings estimates for shares of Bausch Health Companies in a research report issued to clients and investors on Monday, January 20th. Zacks Research analyst R. Department now expects that the company willJanuary 22, 2025 | marketbeat.comBausch Health Companies Inc.: Bausch Health Statement on Selection of XIFAXAN?(rifaximin) for Inflation Reduction Act's Medicare Negotiation ProgramJanuary 17, 2025 | finanznachrichten.deXifaxan selected for CMS drug price talks in 2027January 17, 2025 | msn.comBausch Health Companies (NYSE:BHC) Sees Strong Trading Volume - Here's WhyBausch Health Companies (NYSE:BHC) Sees Large Volume Increase - Should You Buy?January 17, 2025 | marketbeat.comBausch Health Companies Inc. (NYSE:BHC) Receives Average Recommendation of "Hold" from AnalystsBausch Health Companies Inc. (NYSE:BHC - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendJanuary 16, 2025 | marketbeat.comBausch Health, George Medicines sign exclusive licensing agreement or GMRx2January 14, 2025 | markets.businessinsider.comBausch + Lomb Launches enVista Aspireâ„¢ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European UnionJanuary 13, 2025 | businesswire.comGeorge Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central AmericaJanuary 13, 2025 | globenewswire.comIs Bausch Health Companies (BHC) the Best Medical Stock to Buy Under $20?January 12, 2025 | insidermonkey.com12 Best Medical Stocks To Buy Under $20January 11, 2025 | insidermonkey.comInflammX Therapeutics Announces Option Agreement with Bausch + LombJanuary 10, 2025 | globenewswire.com Remove Ads Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Media Mentions By Week BHC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHC News Sentiment▼0.630.68▲Average Medical News Sentiment BHC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHC Articles This Week▼84▲BHC Articles Average Week Remove Ads Get Bausch Health Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ascendis Pharma A/S News Vaxcyte News Qiagen News Roivant Sciences News Sarepta Therapeutics News Revolution Medicines News BridgeBio Pharma News Lantheus News TG Therapeutics News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHC) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
